COLETTE STAKELY: Open Payments
NPI 1881173532 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 49 payments from 12 companies in 2025. Trend: 2023 $415 · 2024 $244 · 2025 $931
Food & beverage: $921Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $253 |
| Novartis Pharmaceuticals Corporation | 9 | $143 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $102 |
| Janssen Biotech, Inc. | 5 | $100 |
| GENZYME CORPORATION | 4 | $85 |
| Incyte Corporation | 4 | $80 |
| UCB, Inc. | 2 | $73 |
| Lilly USA, LLC | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
Products named: RINVOQ, SKYRIZI, COSENTYX, TREMFYA, DUPIXENT, ILUMYA, OPZELURA, Bimzelx.
Industry payments across NY — which companies pay providers there.
